A proof-of-concept, multicenter study of lenvatinib treatment in patients with intermediate‐stage hepatocellular carcinoma
Latest Information Update: 24 Feb 2020
At a glance
- Drugs Lenvatinib (Primary)
- Indications Liver cancer
- Focus Proof of concept; Therapeutic Use
Most Recent Events
- 24 Feb 2020 New trial record
- 25 Jan 2020 Results (N=90), comparison of efficacy between lenvatinib treated group and cTACE treated group as the initial treatment, presented at the 2020 Gastrointestinal Cancers Symposium